Clinical trial for recurrent malignant gliomas using boron neutron capture therapy and bevacizumab
Phase 1
Not yet recruiting
- Conditions
- recurrent malignant glioma
- Registration Number
- JPRN-UMIN000013419
- Lead Sponsor
- Dept. of Neurosurgery, Osaka Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Female patients in definitive or possible pregnancy or in breast-feeding. 2) Patients with phenylketonuria. 3) Patients with grade 3 or 4 in NYHA classification. 4) Patients with cerebrospinal fluid dissemination. 5) Other patients whose participation in the present study is considered inappropriate by a Principal Investigator or Clinical Investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method